Land & Buildings Issues White Paper Detailing Impact of Work From Home Trend On Life Science Office Market

Analysis Shows Employee Attendance in Life Science Buildings with a Combination of Laboratory and Office Space Down 50% Compared to Pre-Pandemic Levels – On Par With Traditional Office Buildings

Following an In-Depth Analysis of Alexandria Real Estate Equities’ Portfolio, Land & Buildings Predicts Shares Could See ~30-40% Downside From Current Levels

Land & Buildings Investment Management, LLC (together with its affiliates, “Land & Buildings”, “us” or “we”), today issued a white paper titled The Work From Home Hurricane Has Hit Life Science Offices, detailing the impact of COVID-19 on the life science office market. Specifically, Land & Buildings’ analysis focused on life science REIT company Alexandria Real Estate Equities, Inc. (NYSE: ARE).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230616782160/en/

With typically 50% laboratory space and 50% office space, many observers have considered companies with office exposure in the life science sector as a safe haven from the impact of the work-from-home phenomenon. Unfortunately, Land & Buildings’ analysis starkly contradicts this view. The full white paper can be found here.

Land & Buildings’ study concludes that if the path for life science follows traditional office, as it appears to be doing, Land & Buildings estimates ARE could trade at valuations similar to traditional coastal office REITs – which suggests an approximate 30-40% downside from current levels.

Previously, in May 2020, Land & Buildings published a white paper titled The New York Office Market is Facing an Existential Hurricane.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.19
+0.94 (0.41%)
AAPL  270.26
+1.26 (0.47%)
AMD  261.75
+3.74 (1.45%)
BAC  52.79
-0.08 (-0.15%)
GOOG  273.55
+5.12 (1.91%)
META  749.15
-2.29 (-0.30%)
MSFT  539.26
-2.81 (-0.52%)
NVDA  206.61
+5.58 (2.78%)
ORCL  276.01
-4.82 (-1.72%)
TSLA  459.95
-0.60 (-0.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.